Risk of tuberculosis in pediatric patients treated with biological agents

Conclusions: There is a risk of LTBI and TB disease under biological agent treatment in children. Care should be taken that TB can be seen during treatment even in patients who did not have LTBI in pretreatment evaluation of biological agents and patients should be controlled frequently in terms of developing LTBI and TB disease.

Source: European Respiratory Journal - October 28, 2020 Category: Respiratory Medicine Authors: Asfuroglu, P., Ramasli Gursoy, T., Onay, Z. R., Sismanlar Eyuboglu, T., Sunar Yayla, E. N., Aslan, A. T., Bakkaloglu Ezgu, S. A., Soylemezoglu, H. O., Buyan, N. Tags: Paediatric respiratory infection and immun. Source Type: research